Target-based biomarker selection–mineralocorticoid receptor-related biomarkers and treatment outcome in major depression

M Büttner, D Jezova, B Greene, C Konrad… - Journal of psychiatric …, 2015 - Elsevier
Aldosterone and mineralocorticoid receptor (MR)-function have been related to depression.
We examined central and peripheral parameters of MR-function in order to characterize their …

Effect of zinc sulfate supplementation on premenstrual syndrome and health‐related quality of life: Clinical randomized controlled trial

S Siahbazi, S Behboudi‐Gandevani… - Journal of Obstetrics …, 2017 - Wiley Online Library
Aim The purpose of study was to assess the effect of zinc sulfate (ZS) supplementation on
premenstrual syndrome (PMS) and health‐related quality of life (QoL). Methods This was a …

Oral contraception

G Evans, EL Sutton - Medical Clinics, 2015 - medical.theclinics.com
Oral Contraception - Medical Clinics Skip to Main Content Skip to Main Menu Medical Clinics
Log in Register Log in Subscribe Claim Main menu theclinics.com theclinics.com External Link …

Therapeutic management of premenstrual syndrome

EW Freeman - Expert opinion on pharmacotherapy, 2010 - Taylor & Francis
Importance of the field: Premenstrual syndrome (PMS) is among the most common health
problems reported by reproductive-age women. Estimates indicate that up to 25% of women …

Treatment of premenstrual dysphoria with continuous versus intermittent dosing of oral contraceptives: Results of a three‐arm randomized controlled trial

TA Eisenlohr‐Moul, SS Girdler… - Depression and …, 2017 - Wiley Online Library
Background Although traditionally dosed combined oral contraceptives (COCs)(21 days of
active pills, 7 days of inactive pills) have not been demonstrated as superior to placebo for …

A Comparative Efficacy of Low‐Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms

J Wichianpitaya… - Obstetrics and …, 2013 - Wiley Online Library
Objective. To compare the efficacy of low‐dose COC containing desogestrel (DSG) with
drospirenone (DRSP) in the changes of premenstrual symptoms. Methods. In an open‐label …

Premenstrual dysphoric disorder without comorbid psychiatric conditions: a systematic review of therapeutic options

G Sepede, F Sarchione, I Matarazzo… - Clinical …, 2016 - journals.lww.com
Objectives Premenstrual dysphoric disorder (PMDD) is a disabling condition affecting
approximately 2% to 8% of women during reproductive age. It has been recently included in …

Negative affect is unrelated to fluctuations in hormone levels across the menstrual cycle: Evidence from a multisite observational study across two successive cycles

MP Hengartner, THC Kruger, K Geraedts… - Journal of …, 2017 - Elsevier
Background Female sex hormones may play a crucial role in the occurrence of cycle-related
mood disorders. However, the literature is inconsistent and methodologically stringent …

Drospirenone: a novel progestin

AJ Rapkin, SA Winer - Expert Opinion on Pharmacotherapy, 2007 - Taylor & Francis
Drospirenone is a novel progestin available in combined oral contraceptives and
menopausal hormonal therapy. Similar to its parent compound spirolactone, an analog of …

Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3 mg administered in a 24/4 regimen: a …

W Koltun, JM Maloney, J Marr, M Kunz - European Journal of Obstetrics & …, 2011 - Elsevier
OBJECTIVE: To investigate the effects of an ethinylestradiol (EE) 20μg/drospirenone (drsp)
3mg combined oral contraceptive (COC) administered in a 24/4 regimen (24 active tablets/4 …